Back
ESC2025 Premium Access

Aspirin versus clopidogrel beyond 1 month after acute coronary syndrome with high bleeding risk or ST-elevation myocardial infarction: pre-specified subanalyses of the STOPDAPT-3

Session: Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention
Topic: Pharmacotherapy
Speaker: Doctor Y. Obayashi (Leiden, NL)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Yuki Obayashi

Leiden University Medical Center, Leiden (Netherlands (The))
0 follower

2 more presentations in this session

Less bleeding by omitting aspirin in non-ST-segment elevation acute coronary syndrome patients (LEGACY)

Speaker: Miss S. Sivanesan (Amsterdam, NL)

Access
Abstract
Slides
Like
Thumbnail

Optimizing antiplatelet therapy in ACS: a network meta-analysis of simplified regimens

Speaker: Doctor N. del-Cuerpo-Salinas (Sant Joan d'Alacant, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel antiplatelet approaches following acute coronary syndromes or percutaneous coronary intervention

Speakers: Doctor Y. Obayashi, Miss S. Sivanesan, Doctor N. del-Cuerpo-Salinas
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources